Effects of thymosin β4 and its N-terminal fragment Ac-SDKP on TGF-β-treated human lung fibroblasts and in the mouse model of bleomycin-induced lung fibrosis

Bibliography

• Goldstein AL, Hannappel E, Kleinman HK. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med 2005;11:421-9
   PubMed Web of Science ®Google Scholar
• Huff T, Muller C S, Otto AM, et al. Beta-Thymosins, small acidic peptides with multiple functions. Int J Biochem Cell Biol 2001;33:205-20
   PubMed Web of Science ®Google Scholar
• Conte E, Genovese T, Gili E, et al. Protective effects of thymosin beta4 in a mouse model of lung fibrosis. Ann N Y Acad Sci 2012;1269:69-73
   PubMed Web of Science ®Google Scholar
• Conte E, Genovese T, Gili E, et al. Thymosin beta4 protects C57BL/6 mice from bleomycin-induced damage in the lung. Eur J Clin Invest 2013;43:309-15
   PubMed Web of Science ®Google Scholar
• Conte E, Iemmolo M, Fagone E, et al. Thymosin beta4 reduces IL-17-producing cells and IL-17 expression, and protects lungs from damage in bleomycin-treated mice. Immunobiology 2014;219:425-31
   PubMed Web of Science ®Google Scholar
• Noble PW, Barkauskas CE, Jiang D. Pulmonary fibrosis: patterns and perpetrators. J Clin Invest 2012;122:2756-62
   PubMed Web of Science ®Google Scholar
• Wolters PJ, Collard HR, Jones KD. Pathogenesis of idiopathic pulmonary fibrosis. Annu Rev Pathol 2014;9:157-79
   PubMed Web of Science ®Google Scholar
• Rafii R, Juarez MM, Albertson TE, et al. A review of current and novel therapies for idiopathic pulmonary fibrosis. J Thorac Dis 2013;5:48-73
   PubMed Web of Science ®Google Scholar
• Li P, Xiao HD, Xu J, et al. Angiotensin-converting enzyme N-terminal inactivation alleviates bleomycin-induced lung injury. Am J Pathol 2010;177:1113-21
   PubMed Web of Science ®Google Scholar
• Castoldi G, di Gioia CR, Bombardi C, et al. Renal antifibrotic effect of N-acetyl-seryl-aspartyl-lysyl-proline in diabetic rats. Am J Nephrol 2013;37:65-73
   PubMed Web of Science ®Google Scholar
• Peng H, Carretero OA, Brigstock DR, et al. Ac-SDKP reverses cardiac fibrosis in rats with renovascular hypertension. Hypertension 2003;42:1164-70
   PubMed Web of Science ®Google Scholar
• Sun Y, Yang F, Yan J, et al. New anti-fibrotic mechanisms of n-acetyl-seryl-aspartyl-lysyl-proline in silicon dioxide-induced silicosis. Life Sci 2010;87:232-9
   PubMed Web of Science ®Google Scholar
• Xu H, Yang F, Sun Y, et al. A new antifibrotic target of Ac-SDKP: inhibition of myofibroblast differentiation in rat lung with silicosis. PLoS One 2012;7:e40301
   PubMed Web of Science ®Google Scholar
• Conte E, Gili E, Fruciano M, et al. PI3K p110gamma overexpression in idiopathic pulmonary fibrosis lung tissue and fibroblast cells: in vitro effects of its inhibition. Lab Invest 2013;93(5):566-76
   PubMed Web of Science ®Google Scholar
• Conte E, Nigro L, Fagone E, et al. Quantitative evaluation of interleukin-12 p40 gene expression in peripheral blood mononuclear cells. Immunol Invest 2008;37:143-51
   PubMed Web of Science ®Google Scholar
• Conte E, Gili E, Fruciano M, et al. PI3K p110gamma overexpression in idiopathic pulmonary fibrosis lung tissue and fibroblast cells: in vitro effects of its inhibition. Lab Invest 2013;93(5):566-76
   PubMed Web of Science ®Google Scholar
• Conte E, Fruciano M, Fagone E, et al. Inhibition of PI3K prevents the proliferation and differentiation of human lung fibroblasts into myofibroblasts: the role of class I P110 isoforms. PLoS One 2011;6:e24663
   PubMed Web of Science ®Google Scholar
• De SM, Inzitari R, Bosello SL, et al. Beta-Thymosins and interstitial lung disease: study of a scleroderma cohort with a one-year follow-up. Respir Res 2011;12:22
   PubMedGoogle Scholar
• Zuo Y, Chun B, Potthoff SA, et al. Thymosin beta4 and its degradation product, Ac-SDKP, are novel reparative factors in renal fibrosis. Kidney Int 2013;84:1166-75
   PubMed Web of Science ®Google Scholar
• Sopko N, Qin Y, Finan A, et al. Significance of thymosin beta4 and implication of PINCH-1-ILK-alpha-parvin (PIP) complex in human dilated cardiomyopathy. PLoS One 2011;6:e20184
   PubMed Web of Science ®Google Scholar
• Bock-Marquette I, Saxena A, White MD, et al. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 2004;432:466-72
   PubMed Web of Science ®Google Scholar
• Reyes-Gordillo K, Shah R, Popratiloff A, et al. Thymosin-beta4 (Tbeta4) blunts PDGF-dependent phosphorylation and binding of AKT to actin in hepatic stellate cells. Am J Pathol 2011;178:2100-8
   PubMed Web of Science ®Google Scholar
• Smart N, Risebro CA, Melville AA, et al. Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization. Nature 2007;445:177-82
   PubMed Web of Science ®Google Scholar
• Kumar S, Gupta S. Thymosin beta 4 prevents oxidative stress by targeting antioxidant and anti-apoptotic genes in cardiac fibroblasts. PLoS One 2011;6:e26912
   PubMed Web of Science ®Google Scholar
• Ehrlich HP, Hazard SW. Thymosin beta4 affecting the cytoskeleton organization of the myofibroblasts. Ann N Y Acad Sci 2012;1269:74-8
   PubMed Web of Science ®Google Scholar
• Peng H, Carretero OA, Peterson EL, et al. Ac-SDKP inhibits transforming growth factor-beta1-induced differentiation of human cardiac fibroblasts into myofibroblasts. Am J Physiol Heart Circ Physiol 2010;298:H1357-64
   PubMed Web of Science ®Google Scholar